International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

Summary - Recent advances in the treatment of multiple myeloma have increased the need for accurate diagnosis of the disease. The detection of bone and bone marrow lesions is crucial in the investigation of multiple myeloma and often dictates the decision to start treatment. Furthermore, detection o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hillengaß, Jens (VerfasserIn) , Usmani, Saad (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 May 2019
In: The lancet. Oncology
Year: 2019, Jahrgang: 20, Heft: 6, Pages: 302-312
ISSN:1474-5488
DOI:10.1016/S1470-2045(19)30309-2
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/S1470-2045(19)30309-2
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1470204519303092
Volltext
Verfasserangaben:Jens Hillengass, Saad Usmani, S Vincent Rajkumar, Brian G M Durie, María-Victoria Mateos, Sagar Lonial, Cristina Joao, Kenneth C Anderson, Ramón García-Sanz, Eloísa Riva Serra, Juan Du, Niels van de Donk, Jesús G Berdeja, Evangelos Terpos, Elena Zamagni, Robert A Kyle, Jesús San Miguel, Hartmut Goldschmidt, Sergio Giralt, Shaji Kumar, Noopur Raje, Heinz Ludwig, Enrique Ocio, Rik Schots, Hermann Einsele, Fredrik Schjesvold, Wen-Ming Chen, Niels Abildgaard, Brea C Lipe, Dominik Dytfeld, Baldeep Mona Wirk, Matthew Drake, Michele Cavo, Juan José Lahuerta, Suzanne Lentzsch

MARC

LEADER 00000caa a2200000 c 4500
001 1667878735
003 DE-627
005 20230427035419.0
007 cr uuu---uuuuu
008 190625s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/S1470-2045(19)30309-2  |2 doi 
035 |a (DE-627)1667878735 
035 |a (DE-599)KXP1667878735 
035 |a (OCoLC)1341229080 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hillengaß, Jens  |d 1974-  |e VerfasserIn  |0 (DE-588)124918549  |0 (DE-627)368073823  |0 (DE-576)294568298  |4 aut 
245 1 0 |a International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders  |c Jens Hillengass, Saad Usmani, S Vincent Rajkumar, Brian G M Durie, María-Victoria Mateos, Sagar Lonial, Cristina Joao, Kenneth C Anderson, Ramón García-Sanz, Eloísa Riva Serra, Juan Du, Niels van de Donk, Jesús G Berdeja, Evangelos Terpos, Elena Zamagni, Robert A Kyle, Jesús San Miguel, Hartmut Goldschmidt, Sergio Giralt, Shaji Kumar, Noopur Raje, Heinz Ludwig, Enrique Ocio, Rik Schots, Hermann Einsele, Fredrik Schjesvold, Wen-Ming Chen, Niels Abildgaard, Brea C Lipe, Dominik Dytfeld, Baldeep Mona Wirk, Matthew Drake, Michele Cavo, Juan José Lahuerta, Suzanne Lentzsch 
264 1 |c 29 May 2019 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.06.2019 
520 |a Summary - Recent advances in the treatment of multiple myeloma have increased the need for accurate diagnosis of the disease. The detection of bone and bone marrow lesions is crucial in the investigation of multiple myeloma and often dictates the decision to start treatment. Furthermore, detection of minimal residual disease is important for prognosis determination and treatment planning, and it has underscored an unmet need for sensitive imaging methods that accurately assess patient response to multiple myeloma treatment. Low-dose whole-body CT has increased sensitivity compared with conventional skeletal survey in the detection of bone disease, which can reveal information leading to changes in therapy and disease management that could prevent or delay the onset of clinically significant morbidity and mortality as a result of skeletal-related events. Given the multiple options available for the detection of bone and bone marrow lesions, ranging from conventional skeletal survey to whole-body CT, PET/CT, and MRI, the International Myeloma Working Group decided to establish guidelines on optimal use of imaging methods at different disease stages. These recommendations on imaging within and outside of clinical trials will help standardise imaging for monoclonal plasma cell disorders worldwide to allow the comparison of results and the unification of treatment approaches for multiple myeloma. 
700 1 |a Usmani, Saad  |e VerfasserIn  |0 (DE-588)1189151065  |0 (DE-627)1667878255  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
773 0 8 |i Enthalten in  |t The lancet. Oncology  |d London : The Lancet Publ. Group, 2000  |g 20(2019), 6, Seite 302-312  |h Online-Ressource  |w (DE-627)325349770  |w (DE-600)2035574-9  |w (DE-576)100517544  |x 1474-5488  |7 nnas  |a International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders 
773 1 8 |g volume:20  |g year:2019  |g number:6  |g pages:302-312  |g extent:11  |a International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders 
856 4 0 |u https://doi.org/10.1016/S1470-2045(19)30309-2  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1470204519303092  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190625 
993 |a Article 
994 |a 2019 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 18 
998 |g 124918549  |a Hillengaß, Jens  |m 124918549:Hillengaß, Jens  |d 910000  |d 910100  |e 910000PH124918549  |e 910100PH124918549  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1667878735  |e 3489576632 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Jens Hillengass, Saad Usmani, S Vincent Rajkumar, Brian G M Durie, María-Victoria Mateos, Sagar Lonial, Cristina Joao, Kenneth C Anderson, Ramón García-Sanz, Eloísa Riva Serra, Juan Du, Niels van de Donk, Jesús G Berdeja, Evangelos Terpos, Elena Zamagni, Robert A Kyle, Jesús San Miguel, Hartmut Goldschmidt, Sergio Giralt, Shaji Kumar, Noopur Raje, Heinz Ludwig, Enrique Ocio, Rik Schots, Hermann Einsele, Fredrik Schjesvold, Wen-Ming Chen, Niels Abildgaard, Brea C Lipe, Dominik Dytfeld, Baldeep Mona Wirk, Matthew Drake, Michele Cavo, Juan José Lahuerta, Suzanne Lentzsch"]},"physDesc":[{"extent":"11 S."}],"recId":"1667878735","relHost":[{"part":{"year":"2019","pages":"302-312","issue":"6","text":"20(2019), 6, Seite 302-312","volume":"20","extent":"11"},"titleAlt":[{"title":"The lancet <London> / Oncology"}],"language":["eng"],"id":{"issn":["1474-5488"],"zdb":["2035574-9"],"eki":["325349770"]},"recId":"325349770","physDesc":[{"extent":"Online-Ressource"}],"disp":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersThe lancet. Oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["0.2000 -"],"origin":[{"dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisher":"The Lancet Publ. Group","publisherPlace":"London"}],"note":["Gesehen am 22.09.2021"],"title":[{"title":"The lancet","partname":"Oncology","title_sort":"lancet"}]}],"id":{"eki":["1667878735"],"doi":["10.1016/S1470-2045(19)30309-2"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"29 May 2019"}],"note":["Gesehen am 25.06.2019"],"title":[{"title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","title_sort":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"given":"Jens","role":"aut","family":"Hillengaß","display":"Hillengaß, Jens"},{"role":"aut","given":"Saad","display":"Usmani, Saad","family":"Usmani"},{"display":"Goldschmidt, Hartmut","family":"Goldschmidt","given":"Hartmut","role":"aut"}]} 
SRT |a HILLENGASSINTERNATIO2920